BTAI - Balance Sheet - BioXcel Therapeutics, Inc.

Current Liabilities	22.2 M
Accounts Payable	16 M
Short-Term Debt	374 K
Other Current Liabilities	5.87 M
Non-Current Liabilities	109 M
Long-Term Debt	103 M
Other Non-Current Liabilities	6.63 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016
ASSETS
Cash & Cash Equivalents	29.9	65.2	193.7	233.0	213.1	32.4	42.6	0.9	0
Short Term Investments	0	0	0	0	0	0	0	0	0
Receivables	0.1	71 K	0.2	0	0	0	0.1	0	0
Inventory	0.7	2.0	2.0	0	0	0	0	0	0
Other Current Assets	6.7	4.9	6.9	3.8	6.9	1.7	0.5	3 K	2 K
Total Current Assets	37.4	72.1	202.9	233.0	217.1	34.1	43.2	0.9	2 K
PP&E	0.9	1.5	2.1	2.5	2.8	2.2	0.3	4 K	5 K
Intangible Assets	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0	0
Other Long Term Assets	87 K	87 K	0.9	3.9	87 K	51 K	51 K	0.5	0
Other Assets	0	0	0	0	0	0	0	0	0
Total Assets	38.3	73.7	205.9	239.4	219.9	36.4	43.5	1.4	7 K
LIABILITIES
Accounts Payable	16.0	13.7	10.2	4.7	4.0	5.0	1.6	0.4	0.3
Short Term Debt	0.4	0.3	0.3	0.3	0.2	0	0	0.4	0
Other Current Liabilities	5.8	13.2	22.3	11.4	6.9	3.5	3.1	1.5	52 K
Total Current Liabilities	22.2	27.3	32.9	16.7	11.8	8.5	4.7	2.3	0.3
Long Term Debt	102.6	101.0	94.6	2.2	2.8	1.0	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0	0	0
Other Liabilities	6.6	1.9	1.6	(1.1)	(1.4)	0	0	0	0
Total Liabilities	131.4	130.2	129.1	17.8	13.2	9.5	4.7	2.3	0.3
EQUITY
Common Stock	49 K	30 K	28 K	28 K	24 K	18 K	16 K	10 K	0
Retained Earnings	(650.2)	(590.6)	(411.5)	(245.8)	(138.9)	(56.7)	(23.7)	(4.5)	0
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	0	18 K	1 K	0
Total Equity	(93.1)	(56.5)	76.8	221.7	206.7	26.9	38.9	(1.0)	(0.3)
Total Liabilities and Equity	38.3	73.7	205.9	239.4	219.9	36.4	43.5	1.4	7 K
SHARES OUTSTANDING
Common Shares Outstanding	2.5	29.1	28.0	26.4	21.7	16.3	14.6	15.2	15.6	15.9

Free